Active, Not Recruiting
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors
NCT04431726
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
- Locations
-
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- University of Colorado Denver, Children's Hospital Aurora, Colorado, United States
- Tulane University Health Sciences Center New Orleans, Louisiana, United States